The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Recombinant Antibody Expression Service Market Research Report 2024

Global Recombinant Antibody Expression Service Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742342

No of Pages : 111

Ask Your Query

Synopsis
Global Recombinant Antibody Expression Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant Antibody Expression Service market research.

Key companies engaged in the Recombinant Antibody Expression Service industry include GenScript Biotech Corporation, Creative Biolabs, Abnova Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Covance Inc., Sino Biological Inc., ProMab Biotechnologies Inc. and LakePharma Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Recombinant Antibody Expression Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant Antibody Expression Service market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Recombinant Antibody Expression Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GenScript Biotech Corporation
  • Creative Biolabs
  • Abnova Corporation
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Covance Inc.
  • Sino Biological Inc.
  • ProMab Biotechnologies Inc.
  • LakePharma Inc.
  • Genetically Modified Animals Inc.
  • Atlas Antibodies AB
  • Absolute Antibody Ltd.
  • ProteoGenix
  • BOC Sciences
  • Rockland Immunochemicals Inc.
  • Molecular Innovations Inc.
  • Proteintech Group Inc.
  • RayBiotech Inc.
  • BioLegend Inc.
  • Genscript USA Inc.
  • Agilent Technologies
  • Novus Biologicals LLC
  • OriGene Technologies Inc.
  • ACROBiosystems
  • Fitzgerald Industries International

Segment by Type

  • Mammalian Cell Expression
  • Bacterial Expression
  • Yeast Expression
  • Insect Cell Expression
  • Cell-Free Expression
  • Transgenic Animal Expression
  • Plant Expression

Segment by Application

  • Research and Development
  • Diagnostics
  • Therapeutics
  • Agriculture and Food
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Recombinant Antibody Expression Service report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Expression Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mammalian Cell Expression
1.2.3 Bacterial Expression
1.2.4 Yeast Expression
1.2.5 Insect Cell Expression
1.2.6 Cell-Free Expression
1.2.7 Transgenic Animal Expression
1.2.8 Plant Expression
1.3 Market by Application
1.3.1 Global Recombinant Antibody Expression Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research and Development
1.3.3 Diagnostics
1.3.4 Therapeutics
1.3.5 Agriculture and Food
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Expression Service Market Perspective (2018-2029)
2.2 Recombinant Antibody Expression Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Expression Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Recombinant Antibody Expression Service Historic Market Size by Region (2018-2023)
2.2.3 Recombinant Antibody Expression Service Forecasted Market Size by Region (2024-2029)
2.3 Recombinant Antibody Expression Service Market Dynamics
2.3.1 Recombinant Antibody Expression Service Industry Trends
2.3.2 Recombinant Antibody Expression Service Market Drivers
2.3.3 Recombinant Antibody Expression Service Market Challenges
2.3.4 Recombinant Antibody Expression Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Expression Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Expression Service Players by Revenue (2018-2023)
3.1.2 Global Recombinant Antibody Expression Service Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Antibody Expression Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Antibody Expression Service Revenue
3.4 Global Recombinant Antibody Expression Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Expression Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Expression Service Revenue in 2022
3.5 Recombinant Antibody Expression Service Key Players Head office and Area Served
3.6 Key Players Recombinant Antibody Expression Service Product Solution and Service
3.7 Date of Enter into Recombinant Antibody Expression Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Expression Service Breakdown Data by Type
4.1 Global Recombinant Antibody Expression Service Historic Market Size by Type (2018-2023)
4.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2024-2029)
5 Recombinant Antibody Expression Service Breakdown Data by Application
5.1 Global Recombinant Antibody Expression Service Historic Market Size by Application (2018-2023)
5.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Recombinant Antibody Expression Service Market Size (2018-2029)
6.2 North America Recombinant Antibody Expression Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Recombinant Antibody Expression Service Market Size by Country (2018-2023)
6.4 North America Recombinant Antibody Expression Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Expression Service Market Size (2018-2029)
7.2 Europe Recombinant Antibody Expression Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Recombinant Antibody Expression Service Market Size by Country (2018-2023)
7.4 Europe Recombinant Antibody Expression Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Expression Service Market Size (2018-2029)
8.2 Asia-Pacific Recombinant Antibody Expression Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Expression Service Market Size (2018-2029)
9.2 Latin America Recombinant Antibody Expression Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Recombinant Antibody Expression Service Market Size by Country (2018-2023)
9.4 Latin America Recombinant Antibody Expression Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Expression Service Market Size (2018-2029)
10.2 Middle East & Africa Recombinant Antibody Expression Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Detail
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation Recombinant Antibody Expression Service Introduction
11.1.4 GenScript Biotech Corporation Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.1.5 GenScript Biotech Corporation Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Detail
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Recombinant Antibody Expression Service Introduction
11.2.4 Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.2.5 Creative Biolabs Recent Development
11.3 Abnova Corporation
11.3.1 Abnova Corporation Company Detail
11.3.2 Abnova Corporation Business Overview
11.3.3 Abnova Corporation Recombinant Antibody Expression Service Introduction
11.3.4 Abnova Corporation Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.3.5 Abnova Corporation Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Recombinant Antibody Expression Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Recombinant Antibody Expression Service Introduction
11.5.4 Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Detail
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Recombinant Antibody Expression Service Introduction
11.6.4 Covance Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.6.5 Covance Inc. Recent Development
11.7 Sino Biological Inc.
11.7.1 Sino Biological Inc. Company Detail
11.7.2 Sino Biological Inc. Business Overview
11.7.3 Sino Biological Inc. Recombinant Antibody Expression Service Introduction
11.7.4 Sino Biological Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.7.5 Sino Biological Inc. Recent Development
11.8 ProMab Biotechnologies Inc.
11.8.1 ProMab Biotechnologies Inc. Company Detail
11.8.2 ProMab Biotechnologies Inc. Business Overview
11.8.3 ProMab Biotechnologies Inc. Recombinant Antibody Expression Service Introduction
11.8.4 ProMab Biotechnologies Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.8.5 ProMab Biotechnologies Inc. Recent Development
11.9 LakePharma Inc.
11.9.1 LakePharma Inc. Company Detail
11.9.2 LakePharma Inc. Business Overview
11.9.3 LakePharma Inc. Recombinant Antibody Expression Service Introduction
11.9.4 LakePharma Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.9.5 LakePharma Inc. Recent Development
11.10 Genetically Modified Animals Inc.
11.10.1 Genetically Modified Animals Inc. Company Detail
11.10.2 Genetically Modified Animals Inc. Business Overview
11.10.3 Genetically Modified Animals Inc. Recombinant Antibody Expression Service Introduction
11.10.4 Genetically Modified Animals Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.10.5 Genetically Modified Animals Inc. Recent Development
11.11 Atlas Antibodies AB
11.11.1 Atlas Antibodies AB Company Detail
11.11.2 Atlas Antibodies AB Business Overview
11.11.3 Atlas Antibodies AB Recombinant Antibody Expression Service Introduction
11.11.4 Atlas Antibodies AB Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.11.5 Atlas Antibodies AB Recent Development
11.12 Absolute Antibody Ltd.
11.12.1 Absolute Antibody Ltd. Company Detail
11.12.2 Absolute Antibody Ltd. Business Overview
11.12.3 Absolute Antibody Ltd. Recombinant Antibody Expression Service Introduction
11.12.4 Absolute Antibody Ltd. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.12.5 Absolute Antibody Ltd. Recent Development
11.13 ProteoGenix
11.13.1 ProteoGenix Company Detail
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Recombinant Antibody Expression Service Introduction
11.13.4 ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.13.5 ProteoGenix Recent Development
11.14 BOC Sciences
11.14.1 BOC Sciences Company Detail
11.14.2 BOC Sciences Business Overview
11.14.3 BOC Sciences Recombinant Antibody Expression Service Introduction
11.14.4 BOC Sciences Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.14.5 BOC Sciences Recent Development
11.15 Rockland Immunochemicals Inc.
11.15.1 Rockland Immunochemicals Inc. Company Detail
11.15.2 Rockland Immunochemicals Inc. Business Overview
11.15.3 Rockland Immunochemicals Inc. Recombinant Antibody Expression Service Introduction
11.15.4 Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.15.5 Rockland Immunochemicals Inc. Recent Development
11.16 Molecular Innovations Inc.
11.16.1 Molecular Innovations Inc. Company Detail
11.16.2 Molecular Innovations Inc. Business Overview
11.16.3 Molecular Innovations Inc. Recombinant Antibody Expression Service Introduction
11.16.4 Molecular Innovations Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.16.5 Molecular Innovations Inc. Recent Development
11.17 Proteintech Group Inc.
11.17.1 Proteintech Group Inc. Company Detail
11.17.2 Proteintech Group Inc. Business Overview
11.17.3 Proteintech Group Inc. Recombinant Antibody Expression Service Introduction
11.17.4 Proteintech Group Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.17.5 Proteintech Group Inc. Recent Development
11.18 RayBiotech Inc.
11.18.1 RayBiotech Inc. Company Detail
11.18.2 RayBiotech Inc. Business Overview
11.18.3 RayBiotech Inc. Recombinant Antibody Expression Service Introduction
11.18.4 RayBiotech Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.18.5 RayBiotech Inc. Recent Development
11.19 BioLegend Inc.
11.19.1 BioLegend Inc. Company Detail
11.19.2 BioLegend Inc. Business Overview
11.19.3 BioLegend Inc. Recombinant Antibody Expression Service Introduction
11.19.4 BioLegend Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.19.5 BioLegend Inc. Recent Development
11.20 Genscript USA Inc.
11.20.1 Genscript USA Inc. Company Detail
11.20.2 Genscript USA Inc. Business Overview
11.20.3 Genscript USA Inc. Recombinant Antibody Expression Service Introduction
11.20.4 Genscript USA Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.20.5 Genscript USA Inc. Recent Development
11.21 Agilent Technologies
11.21.1 Agilent Technologies Company Detail
11.21.2 Agilent Technologies Business Overview
11.21.3 Agilent Technologies Recombinant Antibody Expression Service Introduction
11.21.4 Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.21.5 Agilent Technologies Recent Development
11.22 Novus Biologicals LLC
11.22.1 Novus Biologicals LLC Company Detail
11.22.2 Novus Biologicals LLC Business Overview
11.22.3 Novus Biologicals LLC Recombinant Antibody Expression Service Introduction
11.22.4 Novus Biologicals LLC Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.22.5 Novus Biologicals LLC Recent Development
11.23 OriGene Technologies Inc.
11.23.1 OriGene Technologies Inc. Company Detail
11.23.2 OriGene Technologies Inc. Business Overview
11.23.3 OriGene Technologies Inc. Recombinant Antibody Expression Service Introduction
11.23.4 OriGene Technologies Inc. Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.23.5 OriGene Technologies Inc. Recent Development
11.24 ACROBiosystems
11.24.1 ACROBiosystems Company Detail
11.24.2 ACROBiosystems Business Overview
11.24.3 ACROBiosystems Recombinant Antibody Expression Service Introduction
11.24.4 ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.24.5 ACROBiosystems Recent Development
11.25 Fitzgerald Industries International
11.25.1 Fitzgerald Industries International Company Detail
11.25.2 Fitzgerald Industries International Business Overview
11.25.3 Fitzgerald Industries International Recombinant Antibody Expression Service Introduction
11.25.4 Fitzgerald Industries International Revenue in Recombinant Antibody Expression Service Business (2018-2023)
11.25.5 Fitzgerald Industries International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock